Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 7/2017

Ausgabe 7/2017

Inhaltsverzeichnis ( 12 Artikel )

30.03.2017 | Review | Ausgabe 7/2017 Open Access

Cancer immunotherapy: how low-level ionizing radiation can play a key role

Marek K. Janiak, Marta Wincenciak, Aneta Cheda, Ewa M. Nowosielska, Edward J. Calabrese

13.04.2017 | Opinion Paper | Ausgabe 7/2017

Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow “in situ tumor vaccination”?

Gaël Deplanque, Keyvan Shabafrouz, Michel Obeid

18.03.2017 | Original Article | Ausgabe 7/2017 Open Access

HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients

Margaret R. Dunne, Adriana J. Michielsen, Katie E. O’Sullivan, Mary Clare Cathcart, Ronan Feighery, Brendan Doyle, Jenny A. Watson, Naoimh J. O’Farrell, Narayanasamy Ravi, Elaine Kay, John V. Reynolds, Elizabeth J. Ryan, Jacintha O’Sullivan

20.03.2017 | Original Article | Ausgabe 7/2017 Open Access

A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia

Yukio Kobayashi, Toru Sakura, Shuichi Miyawaki, Kazuyuki Toga, Shinji Sogo, Yuji Heike

25.03.2017 | Original Article | Ausgabe 7/2017

PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer

Riki Okita, Ai Maeda, Katsuhiko Shimizu, Yuji Nojima, Shinsuke Saisho, Masao Nakata

27.03.2017 | Original Article | Ausgabe 7/2017

Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy

Toshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara, Yui Hirata, Kan Kishibe, Yuki Komabayashi, Seigo Ueda, Miki Takahara, Takumi Kumai, Kei Ishibashi, Akemi Kosaka, Naoko Aoki, Kensuke Oikawa, Yuji Uno, Naoko Akiyama, Masatoshi Sado, Hidehiro Takei, Esteban Celis, Yasuaki Harabuchi, Hiroya Kobayashi

08.04.2017 | Original Article | Ausgabe 7/2017

Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer

Wolfgang Lilleby, Gustav Gaudernack, Paal F. Brunsvig, Ljiljana Vlatkovic, Melanie Schulz, Kate Mills, Knut Håkon Hole, Else Marit Inderberg

08.04.2017 | Original Article | Ausgabe 7/2017 Open Access

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment

Gülçin Gezgin, Mehmet Dogrusöz, T. Huibertus van Essen, Wilhelmina G. M. Kroes, Gregorius P. M. Luyten, Pieter A. van der Velden, Vonn Walter, Robert M. Verdijk, Thorbald van Hall, Sjoerd H. van der Burg, Martine J. Jager

11.04.2017 | Original Article | Ausgabe 7/2017 Open Access

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma

Sara M. Melief, Marten Visser, Sjoerd H. van der Burg, Els M. E. Verdegaal

12.04.2017 | Original Article | Ausgabe 7/2017

Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer

Kyu Sang Lee, Yoonjin Kwak, Soyeon Ahn, Eun Shin, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Gheeyoung Choe, Woo Ho Kim, Hye Seung Lee

12.04.2017 | Original Article | Ausgabe 7/2017

Coexpressed modular gene expression reveals inverse correlation between immune responsive transcription and aggressiveness in gastric tumours

Kalaivani Kalamohan, Dhanasekaran Rathinam, Ponmathi Panneerpandian, Kumaresan Ganesan

29.05.2017 | Obituary | Ausgabe 7/2017

Professor Enrico Mihich, 1928–2016

Graham Pawelec, Suzanne Ostrand-Rosenberg

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise